Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Viking Therapeutics, a San Diego, California-based clinical-stage bio/pharmaceutical company, is advancing a dual GLP-1/GIP agonist, VK2735, for treating obesity for both subcutaneous and oral administration
From the cover: l-Carnitine via PPARgamma- and Sirt1-dependent mechanisms attenuates epithelial-mesenchymal transition and renal fibrosis caused by perfluorooctanesulfonate
D., Fernandez-Banet, J., Hallin, J., Vanderpool, D., Briere, D
The role of mitochondria-associated membranes in cellular homeostasis and diseases
.png)
A NEW randomized clinical trial suggests that once-weekly semaglutide may help reduce alcohol consumption and cravings in adults with alcohol use disorder (AUD)
US$ 24.88
![Henry Meds Semaglutide Review [2026]](https://innerbody.imgix.net/henry-semaglutide-with-ondansteron-close-up.jpg)
US$ 23.54
US$ 28.75
US$ 22.16
US$ 27.64
US$ 27.19
